Abstract: An electrode includes thorium as a minor component for a high-pressure discharge lamp, where the electrode rod is free of thorium/thorium oxide, or comprises thorium/thorium oxide, as a minor constituent. A covering member made of refractory metal, free of thorium/thorium oxide, is circumference coated on the electrode rod in the vicinity of the discharge side tip. The entire surface of the electrode rod is completely coated over the range where the covering member extends. The electrode rod tip of the electrode rod is not, or at least partly, coated with the covering member. The part of the electrode tip, which is not coated by the covering member, is free of thorium/thorium oxide.

Abstract: An agonist of the VEGF receptor is useful in the treatment of a disease associated with retarded fetal growth, such as intra-uterine growth retardation. The VEGF against may be a VEGF peptide or a gene construct encoding or expressing such a peptide.

Abstract: A water and oil emulsion mascara composition comprising a plurality of water soluble or dispersible film forming polymers in the aqueous phase and being structured by one or more emulsifiers in solid or semi-solid form.

Abstract: A method of operating a gas turbine engine includes forming at least one stator ring passage within at least a portion of a radially inner surface of a casing. The method also includes providing at least one stator ring segment that is sized to be inserted into the at least one stator ring passage. The method further includes forming at least one radial passage within at least a portion of the at least one stator ring segment such that at least a portion of the at least one radial passage is adjacent to at least one substantially axial stator blade passage.

Abstract: A method of assembling a stator assembly includes coupling at least one stator ring segment to a portion of a casing using at least one circumferential stator ring groove defined in the casing. The method also includes coupling at least one stator blade assembly to a portion of the stator ring segment such that at least one radial passage is at least partially defined by at least one of the stator blade assembly and the stator ring segment. The stator assembly includes at least one first radial passage defined within a portion of the stator ring segment. The assembly also includes at least one second radial passage coupled in flow communication with the first radial passage. The second radial passage is at least partially adjacent to at least one of a portion of the stator blade assembly and a portion of the stator ring segment.

Abstract: A method of operating a gas turbine engine includes forming at least one stator ring passage within at least a portion of a radially inner surface of a casing. The method also includes providing at least one stator ring segment that is sized to be inserted into the at least one stator ring passage. The method further includes forming at least one radial passage within at least a portion of the at least one stator ring segment such that at least a portion of the at least one radial passage is adjacent to at least one substantially axial stator blade passage.

Abstract: The invention relates to radioprotectors of formula (I), processes for their preparation and their use in protecting biological materials from radiation damage. In diagnostic and therapeutic radiology, particularly in cancer radiotherapy, the radioprotectors of the present invention may be used to protect certain normal tissues or structures from radiation damage. The radioprotectors of formula (I) may also have uses in decreasing the effects of irradiation in non-medical scenarios, both civil and military.

Abstract: It has been found that an inhibitor of the renin-angiotensin system is useful for the treatment or prevention of a condition associated with hypoxia or impaired metabolic function or efficiency. In particular, it may be used in connection with therapy of stroke or its recurrence, the acute treatment of myocardial infarction, and the treatment or prevention of wasting or cachexia, and is thus useful in treatment of the symptoms and signs of ageing. It may also be used to enhance function in healthy subjects.

Abstract: The invention describes a light burner (1) comprising a discharge chamber (2) containing a gas sealed in the discharge chamber (2) by a seal (4, 5) and a pair of electrode shafts (6, 7), each of which partially intrudes from the seal (4, 5) into the discharge chamber (2) whereby a wrapping (8, 9), at least partially contained in the seal (4, 5), is freely wound around at least one of the electrode shafts (6, 7) and constrained in its motion by a number of containment elements (P1, P2, P3, P4) positioned along the longitudinal axis of the electrode shaft (6, 7).

Abstract: Vascular endothelial growth factor (VEGF) has utility in the treatment of intimal hyperplasia, hypertension and atherosclerosis, and of conditions susceptible to treatment with agents that produce nitric oxide or prostacyclin. Instead of VEGF, an equivalent agent such as an agonist of VEGF receptors may be given, as may nucleic acid encoding such an agonist. The agent may successfully be administered via the adventitial surface of a blood vessel, e.g. using a device which defines a reservoir between the body wall and the vessel's adventitial surface, the reservoir being at least part-filled by a pharmaceutical formulation containing the agent to be delivered.

Abstract: A method of assembling a stator assembly includes coupling at least one stator ring segment to a portion of a casing using at least one circumferential stator ring groove defined in the casing. The method also includes coupling at least one stator blade assembly to a portion of the stator ring segment such that at least one radial passage is at least partially defined by at least one of the stator blade assembly and the stator ring segment. The stator assembly includes at least one first radial passage defined within a portion of the stator ring segment. The assembly also includes at least one second radial passage coupled in flow communication with the first radial passage. The second radial passage is at least partially adjacent to at least one of a portion of the stator blade assembly and a portion of the stator ring segment.

Abstract: A method for simultaneously measuring one or more properties (e.g. temperature, concentration of NOx and ammonia, etc) in an exhaust gas mixture. Signals from one or more sensors that are cross-sensitive to one or more gases can be combined. A decoupling observer algorithm can be applied, such that these cross-sensitivities are decoupled. The sensors simultaneously obtain an estimate of one or more gases in the diesel exhaust. A decoupling observer algorithm can be structured and arranged to be operable among a plurality of positions corresponding to several internal configurations.

Abstract: A glass substrate, and a information recording medium comprised of a glass substrate, comprising an a alkali-containing calcium aluminosilicate glass comprising SiO2, Al2O3, CaO, and alkali oxides (Li2O+Na2O+K2O) as essential components, specifically comprising the following components, expressed in terms of mole percent (mol %): 55-70% SiO2, 4-15% Al2O3, 0-8% B2O3, 8-20% CaO, 3-12% Na2O+K2O+Li2O, 0-5% MgO, up to 5% BaO and 13-35% MgO+CaO+BaO.

Abstract: A compressor radial bleed manifold and compressor case assembly includes a compressor case having one or more bleed flow exit passages therein; and a discrete bleed manifold mounted on the compressor case and having one or more inlet passages extending radially between a manifold plenum and the one or more exit passages in the mounting boss for bleeding compressor air into the manifold plenum.

Abstract: The present invention concerns vascular endothelial growth factor (VEGF) which has utility in the treatment of intimal hyperplasia, hypertension and atherosclerosis, and of conditions susceptible to treatment with agents that produce nitric oxide or prostacyclin. Instead of VEGF, an equivalent agent such as an agonist of VEGF receptors may be given, as may nucleic acid encoding such an agonist. The agent may successfully be administered via the adventitial surface of a blood vessel, e.g., using a device which defines a reservoir between the body wall and the vessel's adventitial surface, the reservoir being at least part-filled by a pharmaceutical formulation containing the agent to be delivered.

Abstract: An adjuvant chemotherapeutic method for treatment of micrometastases is described. The method comprises administering, to a subject previously treated for resection or reduction of a primary tumor, a chemotherapeutic agent entrapped in liposomes, the liposomes having a coating of hydrophilic polymer chains and a targeting ligand that specifically binds to micrometastases, for delivery of the chemotherapeutic agent to the micrometastases.

Abstract: A liposome composition comprising small, surface-bound effector molecules is disclosed. The liposomes have a surface layer of hydrophilic polymer chains, for enhanced circulation time in the bloodstream. The effector molecules are attached to the distal ends of the polymer chains. In one embodiment, the effector is polymyxin B, for treatment of septic shock.

Abstract: A drug delivery device that includes a capsule for implantation into the body; the capsule further includes a reservoir for containing a substance such as a therapeutic agent, at least one port for allowing the substance to diffuse from or otherwise exit the reservoir, and a nanopore membrane in communication with the capsule at or near the exit port for controlling the rate of diffusion of the substance from the exit port. The device also includes an optional screen for providing structural stability to the nanopore membrane and for keeping the pores of the nanopore membrane clear. One embodiment of the drug delivery device includes an osmotic engine internal to the device for creating fluid flow through the device.

Abstract: Novel stem cell factors, oligonucleotides encoding the same, and methods of production, are disclosed. Pharmaceutical compositions and methods of treating disorders involving blood cells are also disclosed.

Abstract: A stator blade segment for a compressor includes an inner ring segment and an outer ring segment and a plurality of stator blades extending radially between the inner and outer ring segments, the stator blade secured to the outer ring at a shank portion of the blade and loosely held in a slot in the inner ring segment at a tip portion of the blade, the slot formed to substantially match a cross-sectional profile of the tip portion of the blade but sized to create a clearance between the tip portion and the slot.